Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Mar;2(3):197-208.
doi: 10.18632/oncotarget.241.

APC +/- alters colonic fibroblast proteome in FAP

Affiliations

APC +/- alters colonic fibroblast proteome in FAP

Bhavinkumar B Patel et al. Oncotarget. 2011 Mar.

Abstract

Here we compared the proteomes of primary fibroblast cultures derived from morphologically normal colonic mucosa of familial adenomatous polyposis (FAP) patients with those obtained from unaffected controls. The expression signature of about 19% of total fibroblast proteins separates FAP mutation carriers from unaffected controls (P < 0.01). More than 4,000 protein spots were quantified by 2D PAGE analysis, identifying 368 non-redundant proteins and 400 of their isoforms. Specifically, all three classes of cytoskeletal filaments and their regulatory proteins were altered as were oxidative stress response proteins. Given that FAP fibroblasts showed heightened sensitivity to transformation by KiMSV and SV40 including elevated levels of the p53 protein, events controlled in large measure by the Ras suppressor protein-1 (RSU-1) and oncogenic DJ-1, here we show decreased RSU1 and augmented DJ-1 expression in both fibroblasts and crypt-derived epithelial cells from morphologically normal colonic mucosa of FAP gene-carriers. The results indicate that heterozygosity for a mutant APC tumor suppressor gene alters the proteomes of both colon-derived normal fibroblasts in a gene-specific manner, consistent with a "one-hit" effect.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no conflict of interest exists.

Figures

Figure 1
Figure 1. 2D gels of FAP and control colonic fibroblasts.Three overlapping pH range 2D gels across pI 4—11 of FAP and control colonic fibroblasts
These files are also in the Supplemental Data and at our web site after publication and are searchable and hyperlink-enabled to gene ontology on line.
Figure 2
Figure 2. RSU-1 expression in colonic fibroblasts
A. pH 6—11 range 2D gel analysis of RSU-1 protein isoforms in control colon fibroblasts. All the protein spots observed in this picture were identified with mass spectrometry. Four isoforms of RSU-1 are indicated by the arrows. The rightmost spot is unmodified RSU-1. The second spot from the left is lower in intensity in FAP fibroblasts. The right two RSU-1 spots were outside of the range of the pH 5—8 gels previously used to detect changes in RSU-1 levels. B. Western analysis of RSU1 expression in FAP colonic fibroblasts versus control colonic fibroblasts. C. Western analysis of RSU-1 expression in FAP colonic crypt cells versus those from control patients.
Figure 3
Figure 3. DJ-1 proteomic changes in colonic crypts
A. 1D gel Western blotting, B. 2D gel pH4—7 12% SDS-PAGE gels, and mass spectrometry protein identification, and C. 2D gel Western blotting experiments. The circled protein spots were DJ-1 identified by mass spectrometry. Corresponding spots were indicated by arrows in the 2D Western blotting images. For the 2D Western, Control was CP 203, FAP was SID 516.

References

    1. Herbert BS, Chanoux RA, Liu Y, Baenziger PH, Goswami CP, McClintick JN, Edenberg HJ, Pennington RE, Lipkin SM, Kopelovich L. A molecular signature of normal breast epithelial and stromal cells from Li-Fraumeni syndrome mutation carriers. Oncotarget. 2010;1(6):405–22. - PMC - PubMed
    1. Bellacosa A, Godwin AK, Peri S, Devarajan K, Caretti E, Vanderveer L, Bove B, Slater C, Zhou Y, Daly M, et al. Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutations. Cancer Prev Res (Phila Pa) 2010;3(1):48–61. - PMC - PubMed
    1. Stoyanova R, Clapper ML, Bellacosa A, Henske EP, Testa JR, Ross EA, Yeung AT, Nicolas E, Tsichlis N, Li YS, et al. Altered gene expression in phenotypically normal renal cells from carriers of tumor suppressor gene mutations. Cancer Biol Ther. 2004;3(12):1313–21. - PubMed
    1. Yeung AT, Patel BB, Li XM, Seeholzer SH, Coudry RA, Cooper HS, Bellacosa A, Boman BM, Zhang T, Litwin S, et al. One-hit effects in cancer: altered proteome of morphologically normal colon crypts in familial adenomatous polyposis. Cancer Res. 2008;68(18):7579–86. - PMC - PubMed
    1. Serova M, Astorgues-Xerri L, Bieche I, Albert S, Vidaud M, Benhadji KA, Emami S, Vidaud D, Hammel P, Theou-Anton N, et al. Epithelial-to-mesenchymal transition and oncogenic Ras expression in resistance to the protein kinase Cbeta inhibitor enzastaurin in colon cancer cells. Mol Cancer Ther. 2010;9(5):1308–17. - PubMed

Publication types

MeSH terms